Towards Healthcare
Corticosteroids Market Size Envisioned at USD 6.91 Billion by 2033

Corticosteroids Market Size Envisioned at USD 6.91 Billion by 2033

Status: Published Category: Therapeutic Area Insight Code: 5111 Format: PDF / PPT / Excel

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Corticosteroids Market Assessment

  • Overview
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa

North America Corticosteroids Market Assessment

  • Overview
  • North America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • North America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • North America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • North America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • North America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users

Europe Corticosteroids Market Assessment

  • Overview
  • Europe Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • Europe Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • Europe Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • Europe Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • Europe Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users

Asia Pacific Corticosteroids Market Assessment

  • Overview
  • Asia Pacific Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • Asia Pacific Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • Asia Pacific Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • Asia Pacific Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • Asia Pacific Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users

Latin America Corticosteroids Market Assessment

  • Overview
  • Latin America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • Latin America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • Latin America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • Latin America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • Latin America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users

Middle East and Africa Corticosteroids Market Assessment

  • Overview
  • Middle East and Africa Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • Middle East and Africa Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • Middle East and Africa Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • Middle East and Africa Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • Middle East and Africa Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users

Company Profiles

  • Pfizer
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Novartis
  • Merck & Co., Inc.
  • GlaxoSmithKline
  • AstraZeneca
  • Bausch Health Companies Inc.
  • Galderma
  • Cipla
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.

Conclusion & Recommendations

  • Insight Code: 5111
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: February 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a dedicated market research professional with over 2 years of experience in the healthcare industry. Specializing in healthcare market research, she brings valuable expertise in analyzing market trends, evaluating industry dynamics, and providing actionable insights to help businesses stay ahead in a competitive market.

Throughout her career, Deepa has focused on delivering in-depth research on various healthcare segments, including pharmaceuticals, biotechnology, and healthcare services. She excels in identifying emerging opportunities, assessing market risks, and understanding regulatory changes that impact the healthcare sector.

Her ability to synthesize complex data and translate it into clear, concise recommendations makes her a key contributor to successful strategic decision-making. Her work helps organizations better understand consumer behavior, market demands, and the regulatory landscape, facilitating informed business strategies.

With a passion for healthcare research and a commitment to excellence, Deepa continues to provide businesses with the market intelligence they need to thrive in an increasingly complex healthcare environment. Her insights are critical for companies seeking to navigate the evolving healthcare landscape and optimize their market positioning.

FAQ's

Corticosteroids, a class of steroid hormones, are extensively used in medicine for their potent anti-inflammatory and immunosuppressive properties. They treat autoimmune disorders, allergies, asthma, and inflammatory joint diseases like rheumatoid arthritis. Topical corticosteroids effectively address dermatological conditions such as eczema and psoriasis. Furthermore, corticosteroids prevent organ rejection post-transplantation and treat certain cancers and hematologic disorders. Their versatility in modulating the immune response and reducing inflammation makes them indispensable across diverse medical conditions.

Pulmonology emerges as the critical segment propelling the growth of the corticosteroid market. The demand for corticosteroids is notably heightened in pulmonology, driven by their practical use in managing respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other lung-related disorders.

A significant hurdle is the potential for side effects and safety concerns associated with prolonged or inappropriate corticosteroid use. These side effects may include bone loss, weight gain, immune system suppression, and metabolic disturbances.

Centers for Disease Control and Prevention, National Institute of Health, World Health Organization, HHS.gov., SEC.gov., Forum of International Respiratory Societies.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 515

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 515